{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bacterial+Infection&page=23", "query": { "condition": "Bacterial Infection", "page": 23 }, "page_size": 10 }, "pagination": { "page": 23, "page_size": 10, "total_count": 2365, "total_pages": 237, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bacterial+Infection&page=24&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bacterial+Infection&page=22&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T15:30:55.322Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03628924", "title": "A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hidradenitis Suppurativa" ], "interventions": [ { "name": "Guselkumab dose 1", "type": "DRUG" }, { "name": "Guselkumab dose 2", "type": "DRUG" }, { "name": "Guselkumab dose 3", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 184, "start_date": "2018-09-04", "completion_date": "2020-05-22", "has_results": true, "last_update_posted_date": "2025-02-04", "last_synced_at": "2026-10-25T15:30:55.322Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Largo, Florida • Ocala, Florida + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Largo", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Orange Park", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03628924" }, { "nct_id": "NCT03691610", "title": "Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy Volunteers (Meningococcal Infection)" ], "interventions": [ { "name": "Meningococcal Polysaccharide (Serogroups A,C,Y and W) Tetanus Toxoid Conjugate vaccine MenACYW conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal Polysaccharide (serogroups A,C,Y and W-135) Diphtheria Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Diphtheria and Tetanus Toxoids and Acellular Pertussis, inactivated Poliovirus and Haemophilus b Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Diphtheria and Tetanus Toxoids and Acellular Pertussis, Hepatitis B and Inactivated Poliovirus Vaccine", "type": "BIOLOGICAL" }, { "name": "Haemophilus b Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13-valent Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Rotavirus Vaccine, Live, Oral, Pentavalent", "type": "BIOLOGICAL" }, { "name": "Hepatitis B Vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, Mumps, and Rubella Virus Vaccine Live", "type": "BIOLOGICAL" }, { "name": "Varicella Virus Vaccine Live", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "19 Months", "sex": "ALL", "summary": "6 Months to 19 Months" }, "enrollment_count": 950, "start_date": "2018-10-04", "completion_date": "2023-10-20", "has_results": true, "last_update_posted_date": "2024-06-25", "last_synced_at": "2026-10-25T15:30:55.322Z", "location_count": 45, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Bellflower", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03691610" }, { "nct_id": "NCT04038346", "title": "Symptomatic Management of Lyme Arthritis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lyme Arthritis", "Lyme Disease", "Arthritis" ], "interventions": [ { "name": "Naproxen", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Desiree Neville, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "3 Years to 17 Years" }, "enrollment_count": 3, "start_date": "2019-10-01", "completion_date": "2025-05-12", "has_results": true, "last_update_posted_date": "2025-11-17", "last_synced_at": "2026-10-25T15:30:55.322Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04038346" }, { "nct_id": "NCT02203942", "title": "Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bacterial Vaginosis", "Vulvovaginal Candidiasis", "Trichomoniasis" ], "interventions": [ { "name": "NAAT testing", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 300, "start_date": "2014-07", "completion_date": "2015-06", "has_results": false, "last_update_posted_date": "2016-01-27", "last_synced_at": "2026-10-25T15:30:55.322Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02203942" }, { "nct_id": "NCT07891728", "title": "A Multicenter Evaluation of SalivIQ™ Strep A for Detecting Group A Streptococcus From Saliva and Throat Swabs in Patients With Acute Pharyngitis", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Streptococcal Pharyngitis", "Group A Streptococcal Infection" ], "interventions": [ { "name": "qPCR", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "SalivIQ Diagnostics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": null, "sex": "ALL", "summary": "3 Years and older" }, "enrollment_count": 668, "start_date": "2026-10-09", "completion_date": "2027-03-15", "has_results": false, "last_update_posted_date": "2026-10-23", "last_synced_at": "2026-10-25T15:30:55.322Z", "location_count": 3, "location_summary": "Baton Rouge, Louisiana • North Andover, Massachusetts • Dallas, Texas", "locations": [ { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "North Andover", "state": "Massachusetts" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07891728" }, { "nct_id": "NCT00001119", "title": "Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Tetanus Toxoid Vaccine", "type": "BIOLOGICAL" }, { "name": "Indinavir sulfate", "type": "DRUG" }, { "name": "Lamivudine/Zidovudine", "type": "DRUG" }, { "name": "Ritonavir", "type": "DRUG" }, { "name": "Abacavir sulfate", "type": "DRUG" }, { "name": "Amprenavir", "type": "DRUG" }, { "name": "Efavirenz", "type": "DRUG" }, { "name": "Hepatitis B Vaccine (Recombinant)", "type": "BIOLOGICAL" }, { "name": "Lamivudine", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 288, "start_date": "1999-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2011-03-02", "last_synced_at": "2026-10-25T15:30:55.322Z", "location_count": 11, "location_summary": "San Francisco, California • Chicago, Illinois • Boston, Massachusetts + 6 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001119" }, { "nct_id": "NCT01989130", "title": "Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Reproductive Tract Infections" ], "interventions": [ { "name": "Roche AMPLICOR CT/NG", "type": "DEVICE" }, { "name": "Cepheid Xpert CT/NG Test", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "George Washington University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2013-10", "completion_date": "2015-03", "has_results": true, "last_update_posted_date": "2019-08-13", "last_synced_at": "2026-10-25T15:30:55.322Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01989130" }, { "nct_id": "NCT07498153", "title": "Spotting Syphilis: A Dual Point-of-Care Syphilis Screening Initiative in a Low-Resource Healthcare Setting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Syphilis", "HIV Infections" ], "interventions": [ { "name": "Chembio HIV/Syphilis rapid POC test", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "14 Years to 65 Years · Female only" }, "enrollment_count": 153, "start_date": "2025-09-30", "completion_date": "2025-10-02", "has_results": true, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-10-25T15:30:55.322Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07498153" }, { "nct_id": "NCT03852472", "title": "Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hidradenitis Suppurativa", "Acne Inversa" ], "interventions": [ { "name": "Avacopan", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 435, "start_date": "2018-12-21", "completion_date": "2021-03-09", "has_results": true, "last_update_posted_date": "2025-03-17", "last_synced_at": "2026-10-25T15:30:55.322Z", "location_count": 91, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 75 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03852472" }, { "nct_id": "NCT00005572", "title": "A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cytomegalovirus Infections", "Cytomegalovirus Retinitis", "Pneumonia, Pneumocystis Carinii", "HIV Infections" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 90, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2008-08-04", "last_synced_at": "2026-10-25T15:30:55.322Z", "location_count": 16, "location_summary": "Los Angeles, California • San Diego, California • San Francisco, California + 10 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Rafael", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005572" } ] }